Automated Insulin Delivery Benefits Adults with Type 2 Diabetes
A new study published in Diabetes Care found that automated insulin delivery (AID) systems lower A1C levels and increase time in the glucose range for adults with type 2 diabetes, regardless of their C-peptide levels.
Researchers concluded that having a low C-peptide level should not be a prerequisite for AID therapy.
Automated insulin delivery systems can benefit adults with type 2 diabetes, regardless of C-peptide levels.
- The study was published in Diabetes Care.
- AID systems lower A1C levels and increase time in the glucose range.
Author's summary: AID systems benefit type 2 diabetes patients.